Yuting He
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 22
- Circular RNAs in diseases 14
- Cancer-related gene regulation 5
-
- Cancer-related molecular mechanisms research 30
- MicroRNA in disease regulation 7
- Cancer, Lipids, and Metabolism 4
- Co-authors
- Wenzhi Guo (27 shared papers)Qiyao Zhang (13 shared papers)Qingyuan Zheng (10 shared papers)Xiao Yu (8 shared papers)Juan Li (3 shared papers)Jie Li (2 shared papers)Shuijun Zhang (9 shared papers)Xiaorui Liu (1 shared paper)
- Journals
- Frontiers in Cell and Developmental Biology (6 papers)Scientific Reports (4 papers)Biomedicine & Pharmacotherapy (4 papers)Journal of Translational Medicine (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yuting He
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 624
- Molecular Biology 904
- Hepatology 46
- Oncology 154
- Pulmonary and Respiratory Medicine 180
Countries citing papers authored by Yuting He
This map shows the geographic impact of Yuting He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting He more than expected).
Fields of papers citing papers by Yuting He
This network shows the impact of papers produced by Yuting He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting He. The network helps show where Yuting He may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuting He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of m5C-related regulatory genes in the diagnosis and prognosis of hepatocellular carcinoma. | 2020 | 91 |
| 2 | 2019 | 78 | |
| 3 | 2018 | 72 | |
| 4 | 2018 | 64 | |
| 5 | 2023 | 50 | |
| 6 | 2020 | 47 | |
| 7 | 2018 | 45 | |
| 8 | Low expression of LACTB promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma. | 2018 | 44 |
| 9 | 2022 | 42 | |
| 10 | 2023 | 41 | |
| 11 | 2017 | 40 | |
| 12 | 2021 | 37 | |
| 13 | 2019 | 36 | |
| 14 | Distinct 5-methylcytosine profiles of circular RNA in human hepatocellular carcinoma. | 2020 | 32 |
| 15 | 2020 | 31 | |
| 16 | 2021 | 29 | |
| 17 | 2015 | 28 | |
| 18 | 2020 | 25 | |
| 19 | 2018 | 24 | |
| 20 | 2024 | 23 |
About Yuting He
Yuting He is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Surgery and Pulmonary and Respiratory Medicine, having authored 65 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (30 papers), RNA modifications and cancer (22 papers), Circular RNAs in diseases (14 papers), MicroRNA in disease regulation (7 papers), Ferroptosis and cancer prognosis (6 papers), Mycobacterium research and diagnosis (6 papers), Cancer-related gene regulation (5 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (624 citations), Molecular Biology (904 citations), Hepatology (46 citations), Oncology (154 citations) and Pulmonary and Respiratory Medicine (180 citations). Yuting He has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wenzhi Guo, Qiyao Zhang, Qingyuan Zheng, Xiao Yu, Juan Li, Jie Li, Shuijun Zhang, Xiaorui Liu, Xiao Yu and Yan Yu. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Scientific Reports, Biomedicine & Pharmacotherapy, Journal of Translational Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.